Sacral Neurostimulation in Neurogenic Lower Urinary Tract and Bowel Dysfunction Caused by Multiple System Atrophy
Neurourology and Urodynamics · 2025
DOI: 10.1002/nau.70091 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neurourology and Urodynamics, 2025. Verfasst von André Reitz und 3 weiteren Autor:innen. Beteiligte Einrichtung: KontinenzZentrum Hirslanden, Zurich, Switzerland. Hauptthemen laut MEDLINE: Multiple System Atrophy, Electric Stimulation Therapy, Lower Urinary Tract Symptoms, Lumbosacral Plexus. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 22 Literaturangaben. Gefördert von: The authors received no specific funding for this work..
Abstract (Originalsprache)
Objective
Multiple system atrophy (MSA) is a progressive neurodegenerative disorder categorized as an atypical Parkinsonian syndrome, affecting extrapyramidal, pyramidal, cerebellar, and autonomic systems. Lower urinary tract dysfunction (LUTD), including urgency, frequency, urge incontinence, and incomplete voiding, is a prevalent symptom, often appearing early in the disease. Conservative treatments, such as anticholinergic and alpha‐blocker therapies, frequently fail due to poor tolerance and limited efficacy. Many patients also experience bowel symptoms, including constipation and fecal incontinence. This study evaluates sacral neuromodulation (SNM) as a treatment option for LUTD and bowel symptoms in advanced MSA. Materials and Methods In this retrospective case series eight patients (4 females, 4 males; mean age 53 years, range 45–61) with refractory LUTD and bowel symptoms underwent detailed urodynamic evaluations and percutaneous sacral nerve test stimulation. Electrodes were placed bilaterally at the S3 and S4 sacral nerve roots under local anesthesia. During an 8‐day test phase, unilateral and bilateral stimulations were applied at frequencies of 3–120 Hz. Success was defined as a ≥ 50% reduction in symptoms, assessed through bladder diaries.
Results
Seven patients qualified for permanent SNM implantation (4 unilateral S3, 3 bilateral S3/S4). At 2 months postimplantation, six patients exhibited ≥ 50% LUT symptom reduction. One patient showed improvement after reprogramming at 9 months. During a median 35‐month follow‐up, LUT relief was maintained in 36 of 44 visits, with reprogramming required in 19. SNM efficacy diminished over time, with five patients eventually requiring suprapubic tubes. Initially, three patients reported bowel symptoms; during follow‐up, four additional cases emerged. Despite waning LUT effects, SNM facilitated defecation in some patients.
Discussion
This retrospective case series indicate that SNM targeting S3 and S4 nerves offers temporary relief for LUTD and bowel symptoms in advanced MSA. Further research is necessary to optimize patient selection, stimulation parameters, and long‐term management strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- KontinenzZentrum Hirslanden, Zurich, Switzerland.
- Department of Urology and Pediatric Urology, University Medical Center of Johannes Gutenberg University, Mainz, Germany.
- St. Elisabeth Hospital, Straubing, Germany.
- Alfried Krupp Hospital Steele, Essen, Germany.
ORCID-Profile: André Reitz
Förderung
- The authors received no specific funding for this work.
Zitieren
APA
Reitz, A., Haferkamp, A., Gilfrich, C., & Buse, S. (2025). Sacral Neurostimulation in Neurogenic Lower Urinary Tract and Bowel Dysfunction Caused by Multiple System Atrophy. Neurourology and Urodynamics. https://doi.org/10.1002/nau.70091
Vancouver
Reitz A, Haferkamp A, Gilfrich C, Buse S. Sacral Neurostimulation in Neurogenic Lower Urinary Tract and Bowel Dysfunction Caused by Multiple System Atrophy. Neurourology and Urodynamics. 2025. doi:10.1002/nau.70091
BibTeX
@article{Reitz2025,
author = {Reitz, André and Haferkamp, Axel and Gilfrich, Christian and Buse, Stephan},
title = {Sacral Neurostimulation in Neurogenic Lower Urinary Tract and Bowel Dysfunction Caused by Multiple System Atrophy},
journal = {Neurourology and Urodynamics},
year = {2025},
doi = {10.1002/nau.70091}
}
EUVIMED